U.S. Chamber Welcomes Section 301 Investigation into German Drug Pricing
June 19, 2026
June 19, 2026
WASHINGTON, June 19 [Category: Business] -- The U.S. Chamber of Commerce posted the following news release:
* * *
U.S. Chamber Welcomes Section 301 Investigation into German Drug Pricing
Marjorie A. Chorlins, Senior Vice President for Europe at the U.S. Chamber of Commerce, issued the following statement in response to USTR's announcement of a Section 301 investigation on Germany's drug pricing policies:
"The U.S. Chamber welcome . . .
* * *
U.S. Chamber Welcomes Section 301 Investigation into German Drug Pricing
Marjorie A. Chorlins, Senior Vice President for Europe at the U.S. Chamber of Commerce, issued the following statement in response to USTR's announcement of a Section 301 investigation on Germany's drug pricing policies:
"The U.S. Chamber welcome . . .
